Literature DB >> 23480247

Symptoms of depression and smoking behaviors following treatment with transdermal nicotine patch.

Robert A Schnoll1, Frank T Leone, Brian Hitsman.   

Abstract

Subscales from the Center for Epidemiologic Studies depression scale (CESD), assessed prior to treatment, were examined as predictors of withdrawal, craving, and affect during the first week of abstinence, as well as smoking abstinence during the first week of abstinence and at the end of treatment. The negative affect and somatic features CESD subscales were related to higher levels of nicotine withdrawal. The relationship between the interpersonal disturbance CESD subscale and nicotine withdrawal approached significance. This study suggests the need to examine novel psychological mechanisms that may account for the relationship between depression symptoms and smoking cessation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23480247      PMCID: PMC3605741          DOI: 10.1080/10550887.2012.759870

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  33 in total

1.  Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity.

Authors:  Delia Dempsey; Piotr Tutka; Peyton Jacob; Faith Allen; Kerri Schoedel; Rachel F Tyndale; Neal L Benowitz
Journal:  Clin Pharmacol Ther       Date:  2004-07       Impact factor: 6.875

2.  Development and validation of brief measures of positive and negative affect: the PANAS scales.

Authors:  D Watson; L A Clark; A Tellegen
Journal:  J Pers Soc Psychol       Date:  1988-06

Review 3.  Meta-analysis of the factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and Zung.

Authors:  Alan B Shafer
Journal:  J Clin Psychol       Date:  2006-01

4.  Depression and smoking cessation: characteristics of depressed smokers and effects of nicotine replacement.

Authors:  T Kinnunen; K Doherty; F S Militello; A J Garvey
Journal:  J Consult Clin Psychol       Date:  1996-08

5.  Effect of nicotine on the tobacco withdrawal syndrome.

Authors:  J R Hughes; D K Hatsukami; R W Pickens; D Krahn; S Malin; A Luknic
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Bupropion SR and counseling for smoking cessation in actual practice: predictors of outcome.

Authors:  Gary E Swan; Lisa M Jack; Sue Curry; Michael Chorost; Harold Javitz; Tim McAfee; Sara Dacey
Journal:  Nicotine Tob Res       Date:  2003-12       Impact factor: 4.244

7.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

Authors:  T F Heatherton; L T Kozlowski; R C Frecker; K O Fagerström
Journal:  Br J Addict       Date:  1991-09

8.  Depressive symptoms and smoking cessation among inner-city African Americans using the nicotine patch.

Authors:  Delwyn Catley; Jasjit S Ahluwalia; Ken Resnicow; Niaman Nazir
Journal:  Nicotine Tob Res       Date:  2003-02       Impact factor: 4.244

9.  Depression, smoking abstinence and HPA function in women smokers.

Authors:  Ovide F Pomerleau; Cynthia S Pomerleau; Sandy M Snedecor; Stefanie Gaulrapp; Rebecca Namenek Brouwer; Oliver G Cameron
Journal:  Hum Psychopharmacol       Date:  2004-10       Impact factor: 1.672

10.  Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial.

Authors:  Caryn Lerman; Vyga Kaufmann; Margaret Rukstalis; Freda Patterson; Kenneth Perkins; Janet Audrain-McGovern; Neal Benowitz
Journal:  Ann Intern Med       Date:  2004-03-16       Impact factor: 25.391

View more
  9 in total

1.  Evidence for the involvement of NMDA receptors in the antidepressant-like effect of nicotine in mouse forced swimming and tail suspension tests.

Authors:  Arya Haj-Mirzaian; Nastaran Kordjazy; Arvin Haj-Mirzaian; Sattar Ostadhadi; Mehdi Ghasemi; Shayan Amiri; Mehrdad Faizi; AhmadReza Dehpour
Journal:  Psychopharmacology (Berl)       Date:  2015-07-15       Impact factor: 4.530

2.  Positive Affect as a Predictor of Smoking Cessation and Relapse: Does It Offer Unique Predictive Value among Depressive Symptom Domains?

Authors:  Jaimee L Heffner; Kristin E Mull; Jennifer B McClure; Jonathan B Bricker
Journal:  Subst Use Misuse       Date:  2017-11-21       Impact factor: 2.164

3.  Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial.

Authors:  Robert M Anthenelli; Michael Gaffney; Neal L Benowitz; Robert West; Thomas McRae; Cristina Russ; David Lawrence; Lisa St Aubin; Alok Krishen; A Eden Evins
Journal:  J Gen Intern Med       Date:  2019-03-07       Impact factor: 5.128

4.  Depressive symptom domains and alcohol use severity among Hispanic emerging adults: Examining moderating effects of gender.

Authors:  Miguel Ángel Cano; Marcel A de Dios; Virmarie Correa-Fernández; Sarah Childress; Jocelyn L Abrams; Angelica M Roncancio
Journal:  Addict Behav       Date:  2017-03-27       Impact factor: 3.913

5.  Anhedonia, depressed mood, and smoking cessation outcome.

Authors:  Adam M Leventhal; Megan E Piper; Sandra J Japuntich; Timothy B Baker; Jessica W Cook
Journal:  J Consult Clin Psychol       Date:  2013-11-11

Review 6.  Cigarette smoking and depression comorbidity: systematic review and proposed theoretical model.

Authors:  Amanda R Mathew; Lee Hogarth; Adam M Leventhal; Jessica W Cook; Brian Hitsman
Journal:  Addiction       Date:  2016-10-26       Impact factor: 6.526

7.  Is a cancer diagnosis a teachable moment for the patient's relative who smokes?

Authors:  Robert A Schnoll; E Paul Wileyto; Frank T Leone; Corey Langer; Richard Lackman; Tracey Evans
Journal:  Cancer Causes Control       Date:  2013-04-19       Impact factor: 2.506

8.  Smoking- and menstrual-related symptomatology during short-term smoking abstinence by menstrual phase and depressive symptoms.

Authors:  Sharon S Allen; Alicia M Allen; Nicole Tosun; Scott Lunos; Mustafa al'Absi; Dorothy Hatsukami
Journal:  Addict Behav       Date:  2014-02-13       Impact factor: 3.913

9.  Effects of Varenicline, Depressive Symptoms, and Region of Enrollment on Smoking Cessation in Depressed Smokers.

Authors:  Neal Doran; Sarah Dubrava; Robert M Anthenelli
Journal:  Nicotine Tob Res       Date:  2019-01-04       Impact factor: 4.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.